4.7 Article

18F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response

Matt Vanderhoek et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

Article Oncology

High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma

Hyun Woo Chung et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

Amandeep Kumar et al.

EUROPEAN RADIOLOGY (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Prediction Model of Chemotherapy Response in Osteosarcoma by 18F-FDG PET and MRI

Gi Jeong Cheon et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Repeatability of F-18-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies

Linda M. Velasquez et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

Richard L. Wahl et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

F-18-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma

Colleen M. Costelloe et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET

Zhaoming Ye et al.

ANNALS OF NUCLEAR MEDICINE (2008)